Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass-Reference-Cited by-同舟云学术

Pro: The Hepcon HMS Should Be Used Instead of Traditional Activated Clotting Time (ACT) to Dose Heparin and Protamine for Cardiac Surgery Requiring Cardiopulmonary Bypass

Published:2016-12 Issue:6 Volume:30 Page:1727-1729
ISSN:1053-0770
Container-title:Journal of Cardiothoracic and Vascular Anesthesia
language:en
Short-container-title:Journal of Cardiothoracic and Vascular Anesthesia

Author:

Ural Kelly,Owen Christopher

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations;Despotis;J Thorac Cardiovasc Surg,1994

2. Heparin monitoring during cardiac surgery. Part 1: Validation of whole-blood heparin concentration and activated clotting time;Raymond;Perfusion,2003

3. Real time measurement of heparin concentration during cardiopulmonary bypass;Hashimoto;J Cardiovasc Surg (Torino),1999

4. The activated coagulation time: Suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery;Martindale;J Cardiothorac Vasc Anesth,1996

5. Anticoagulation monitoring during cardiac surgery: A review of current and emerging techniques;Despotis;Anesthesiology,1999

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Point-of-Care-Directed Coagulation Management in Pediatric Cardiac Surgery;The Thoracic and Cardiovascular Surgeon;2024-08-13

2. Guidelines on the investigation and management of antiphospholipid syndrome;British Journal of Haematology;2024-07-19

3. Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice;Seminars in Thrombosis and Hemostasis;2024-05-29

4. Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding;The Journal of ExtraCorporeal Technology;2023-09

5. Efficacy of the Hepcon system in reducing hemorrhagic and thrombotic complications in antiphospholipid syndrome patients undergoing cardiac surgery;Perfusion;2023-08-22